Choi, Woonyoung <br/><br/>
ERCC2 Mutation: The Marker for Chemosensitivity in Primary and Secondary Muscle-invasive Bladder Cancers.  [electronic resource] 

 -  European urology  02 2019 
 - 240-241 p.  digital 
<br/><br/> Publication Type: Editorial; Comment 
<br/><br/><label>ISSN: </label>1873-7560 
<br/><br/><label>Standard No.: </label>10.1016/j.eururo.2018.09.043  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cisplatin<br/>Genomics<br/>Humans<br/>Mutation<br/>Neoadjuvant Therapy<br/>Urinary Bladder Neoplasms<br/>Xeroderma Pigmentosum Group D Protein--genetics